Growth Metrics

Ligand Pharmaceuticals (LGND) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.24%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 30.54%
10 Ligand Pharmaceuticals 4.55 Bn 3.77 Bn 48.45 Mn -122.02%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -122.02%
Dec 31, 2025 -35.46%
Sep 30, 2025 -173.38%
Jun 30, 2025 -31.65%
Mar 31, 2025 -64.97%
Dec 31, 2024 -2.65%
Sep 30, 2024 -36.67%
Jun 30, 2024 -69.06%
Mar 31, 2024 -27.20%
Dec 31, 2023 70.03%
Sep 30, 2023 -27.21%
Jun 30, 2023 31.66%
Mar 31, 2023 -67.54%
Dec 31, 2022 51.33%
Sep 30, 2022 -51.64%
Jun 30, 2022 -47.78%
Mar 31, 2022 6.31%
Dec 31, 2021 -28.66%
Sep 30, 2021 38.48%
Jun 30, 2021 26.68%
Mar 31, 2021 57.93%
Dec 31, 2020 -119.43%
Sep 30, 2020 98.94%
Jun 30, 2020 -38.95%
Mar 31, 2020 141.13%
Dec 31, 2019 6.76%
Sep 30, 2019 221.99%
Jun 30, 2019 144.36%
Mar 31, 2019 47.18%
Dec 31, 2018 196.20%
Sep 30, 2018 -43.71%
Jun 30, 2018 -101.03%
Mar 31, 2018 -128.98%
Dec 31, 2017 -176.51%
Sep 30, 2017 -819.13%
Jun 30, 2017 300.77%
Mar 31, 2017 -195.18%
Dec 31, 2016 -326.75%
Sep 30, 2016 183.26%
Jun 30, 2016 90.69%
Mar 31, 2016 -1,228.73%
Dec 31, 2015 -442.21%
Sep 30, 2015 -123.30%
Jun 30, 2015 -568.27%
Mar 31, 2015 -39.40%
Dec 31, 2014 9.11%
Sep 30, 2014 36.31%
Jun 30, 2014 10.37%
Mar 31, 2014 64.95%
Dec 31, 2013 -43.83%
Sep 30, 2013 -26.61%